Results for “ ”

Entry Author Date Location
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs 05/28/20 Seattle
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations 05/27/20 New York
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment 05/22/20 Boston
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study 05/11/20 National
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs 05/08/20 National
PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug 05/07/20 New York
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M 05/04/20 New York
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine 05/01/20 Europe
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Page 2 of 155 « previous page · next page »